Yes, must be getting an announcement tomorrow prior to the briefing session in the afternoon.
There's no way MST could know this / present this otherwise. Seems bizarre to publish this updated clinical program, I would have thought the clinical P1a/b data would inform future programs? This could all be out the window again in 6 months...
We haven't heard anything about melanoma since June 2022:
https://raceoncology.com/zantrene-improves-cancer-immunotherapy-in-a-mouse-model-of-treatment-resistant-melanoma/
Keytruda synergy pls....
Yes, must be getting an announcement tomorrow prior to the...
-
- There are more pages in this discussion • 119 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.045(3.01%) |
Mkt cap ! $247.1M | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.52 | $1.45 | $62.74K | 42.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14110 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 666 | 1 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |